Clovis Oncology reported $-66451000 in Pre-Tax Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Abbvie ABBV:US $ 6290M 282M
Acadia Pharmaceuticals ACAD:US $ -43.4M 23.03M
Acceleron Pharma XLRN:US $ -63.51M 0.05M
Acorda Therapeutics ACOR:US $ -28.7M 9.15M
Agenus AGEN:US $ -83.99M 29.59M
Agios Pharmaceuticals AGIO:US $ -82.79M 8.09M
Anika Therapeutics ANIK:US $ 9.13M 7.92M
Arrowhead Research ARWR:US $ -29.92M 3.11M
Cerulean Pharma CERU:US $ -9.16M 1.84M
Clovis Oncology CLVS:US $ -66.45M 0.04M
Eli Lilly And LLY:US $ 1988.6M 80.6M
Enanta Pharmaceuticals ENTA:US $ -33.41M 4.25M
Esperion Therapeutics ESPR:US $ -43668000 47.27M
Five Prime Therapeutics FPRX:US $ -20.85M 0M
GlaxoSmithKline GSK:LN 1482M 225M
Halozyme Therapeutics HALO:US $ 91.52M 36.81M
Heron Therapeutics HRTX:US $ -61.02M 8.4M
Insmed INSM:US $ -116699000 25.3M
Intrexon XON:US $ -20.12M 1.77M
Ligand Pharmaceuticals LGND:US $ 34.99M 4.55M
Neurocrine Biosciences NBIX:US $ 57.5M 30.3M
Novartis NOVN:VX SF 4424M 620M
Rigel Pharmaceuticals RIGL:US $ -14.79M 56.06M
Sangamo Biosciences SGMO:US $ -47.15M 1.47M
Ultragenyx Pharmaceutical RARE:US $ -121.96M 13.8M
Veracyte VCYT:US $ 9.19M 19.75M
YTE INCY:US $ 199.6M 31.06M